Masarykuv onkologicky ustav - Oddeleni klinickych hodnoceni

Brno 656 53

1 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) — Recruiting now